Sign in or Join FriendFeed
FriendFeed is the easiest way to share online. Learn more »
Robin L. Smith

Robin L. Smith

NeoStem® is the first company to provide adult stem cell collection and banking services to the general adult population.
$NBS announces investor conf call & webcast Nov 18 @8AM EST following Nov 17 release of Ph 2 PreSERVE AMI trial data
NeoStem Ph 2 PreSERVE AMI data to be presented Nov 17 & 18 at AHA Scientific Sessions $NBS #Ischemia
NeoStem data from Ph 2 PreSERVE AMI clinical trial to be presented at American Heart Association Scientific Sessions
"We welcome these new additions to our team." CEO Dr. Robin L. Smith on addition of 3 key leaders to $NBS management
Anna Crivici, PhD, joins NeoStem as Vice President, Operations & Program Management
Ann Daus, PhD, joins NeoStem subsidiary Progenitor Cell Therapy as Vice President, Quality
Harry Lam, PhD, joins NeoStem subsidiary Progenitor Cell Therapy as VP, Manufacturing and Technical Operations
NeoStem’s cancer immunotherapy experts to present posters at this week’s SITC Annual Meeting $NBS #immunotherapy
$NBS announces 3 key additions to management team to support manufacturing, quality, and cell therapy program goals
Learn more about NeoStem conference presentations taking place this week $NBS
NeoStem announced today the addition of 3 experienced leaders in the biotech industry to its management team $NBS
NeoStem's Dr. Michael Bayer to present a poster at SITC Annual Meeting @sitcancer #immunotherapy
NeoStem to present posters on Targeted Cancer Immunotherapy Program at SITC Annual Meeting #immunotherapy @sitcancer
$NBS' Dr. Robert Dillman to present poster on Targeted Cancer Immunotherapy Program at SITC Annual Meeting @sitcancer
RT @alliancerm: @NeoStemInc EVP, Stephen Potter, giving company presentation at #SCMOM14 on the co.'s clinical timeline & business model
Join us at the 1st Annual Zacks SCR Healthcare Meetup Sept. 8th at 7pm. We look forward to seeing you there $NBS
Boston Therapeutics (BTHE) Completes Enrollment of Patients With Type 2 Diabetes in Phase IIb Study on BTI-320 in the U.S. -
CVac™ CAN-003 Abstract Accepted For Poster Presentation At The Society For Immunotherapy Of Cancer Annual Meeting $PBMD -
Celator(R) Pharmaceuticals (CPXX) Initiates Pharmacokinetic and Pharmacodynamics Clinical Study of CPX-351 -
Anavex (AVXL) Reports That Antidepressant Fluvoxamine Reduces Stress Through Sigma-1 Receptor -
WaferGen Announces Appointment of Chief Operating Officer and Chief Financial Officer -
Boston Therapeutics (BTHE) Appoints Noted Diabetes Specialist Jaime A. Davidson, M.D. to Its Medical Advisory Board -
“Wocket™ In Your Pocket” Celebrity Ad Campaign for Wocket Smart Wallet Continues with Former World Champion Boxer Vinny Paz -
New Images from Social Media Consumer Wocket Smart Wallet Competition “Show Us Your Wallet”, #Needawocket -
CBD Energy (CBDE) Acquires Equity Interest In Environmental Engineering Group; Secures additional 100MW pipeline -
Capricor Therapeutics (CAPR) Reports Second Quarter 2014 Financial & Business Highlights -
NeoStem Announces Second Quarter 2014 Financial Results and Provides Business Update $NBS
Why are adult #stemcells important? Click to learn more: $NBS
Surgeon General addressed #skincancer as major public concern reporting nearly 5M Americans are treated annually $NBS
RT @cnnbrk: For the first time, U.S. surgeon general issues skin cancer warning.
Other ways to read this feed:Feed readerFacebook